chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Full blood count, Laboratory test, Troponin
Clinical narrative: cardiac arrest/ her heart was barely beating; hypothermia; unable to speak or keep her eyes open; unable to speak or keep her eyes open; unable to stand; She appeared incoherent; terrible dizziness; headache; stomach pain; This is a spontaneous report from a contactable consumer. An 89-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: FF8841) via an unspecified route of administration, administered on the left arm on 01Oct2021 14:00 (at the age of 89-year-old) as dose 3 (booster), single for COVID-19 immunization. Medical history included hypertension. Concomitant medications included tramadol; meprobamate; and amlodipine. The patient previously received first dose of Comirnaty on 21Jan2021 03:00 PM (Batch/Lot No: EL1283) at the left arm and second dose on 15Feb2021 02:30 PM (Batch/Lot No: EW18909) at the left arm for COVID-19 immunisation. By 5:30pm on 01Oct2021 the patient began having terrible dizziness, headache and stomach pain. Those symptoms did not subside and by 11:30am on 02Oct2021 the reporter went to her house (her sister was there) and her mom was hunched over, unable to speak or keep her eyes open, and she was unable to stand. They could not get her to take in any fluids or eat. She appeared incoherent. They called her doctor who suggested they call the number. The paramedics came and her heart was barely beating. They did CPR and got a faint beat. By the time she arrived at (Hospital name/city name) she had cardiac arrest and hypothermia. Thankfully, they revived her. She was given antibiotics, electrolytes and was put on a ventilator and transducer pacemaker. Their concern was on 01Oct2021 at 1:59pm their mom was perfectly fine. By 5:30pm on 01Oct2021 everything changed. No one should have to suffer like this because of a shot. The events resulted in Emergency room/department or urgent care visit and Hospitalization for 3 days. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac arrest, Cardiac pacemaker insertion, Dialysis, Dizziness, Feeling abnormal
Clinical narrative: cardiac arrest/ her heart was barely beating; hypothermia; unable to speak or keep her eyes open; unable to speak or keep her eyes open; unable to stand; She appeared incoherent; terrible dizziness; headache; stomach pain; This is a spontaneous report from a contactable consumer. An 89-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: FF8841) via an unspecified route of administration, administered on the left arm on 01Oct2021 14:00 (at the age of 89-year-old) as dose 3 (booster), single for COVID-19 immunization. Medical history included hypertension. Concomitant medications included tramadol; meprobamate; and amlodipine. The patient previously received first dose of Comirnaty on 21Jan2021 03:00 PM (Batch/Lot No: EL1283) at the left arm and second dose on 15Feb2021 02:30 PM (Batch/Lot No: EW18909) at the left arm for COVID-19 immunisation. By 5:30pm on 01Oct2021 the patient began having terrible dizziness, headache and stomach pain. Those symptoms did not subside and by 11:30am on 02Oct2021 the reporter went to her house (her sister was there) and her mom was hunched over, unable to speak or keep her eyes open, and she was unable to stand. They could not get her to take in any fluids or eat. She appeared incoherent. They called her doctor who suggested they call the number. The paramedics came and her heart was barely beating. They did CPR and got a faint beat. By the time she arrived at (Hospital name/city name) she had cardiac arrest and hypothermia. Thankfully, they revived her. She was given antibiotics, electrolytes and was put on a ventilator and transducer pacemaker. Their concern was on 01Oct2021 at 1:59pm their mom was perfectly fine. By 5:30pm on 01Oct2021 everything changed. No one should have to suffer like this because of a shot. The events resulted in Emergency room/department or urgent care visit and Hospitalization for 3 days. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypopnoea, Mechanical ventilation, Nausea, Septic shock, Somnolence
Clinical narrative: cardiac arrest/ her heart was barely beating; hypothermia; unable to speak or keep her eyes open; unable to speak or keep her eyes open; unable to stand; She appeared incoherent; terrible dizziness; headache; stomach pain; This is a spontaneous report from a contactable consumer. An 89-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: FF8841) via an unspecified route of administration, administered on the left arm on 01Oct2021 14:00 (at the age of 89-year-old) as dose 3 (booster), single for COVID-19 immunization. Medical history included hypertension. Concomitant medications included tramadol; meprobamate; and amlodipine. The patient previously received first dose of Comirnaty on 21Jan2021 03:00 PM (Batch/Lot No: EL1283) at the left arm and second dose on 15Feb2021 02:30 PM (Batch/Lot No: EW18909) at the left arm for COVID-19 immunisation. By 5:30pm on 01Oct2021 the patient began having terrible dizziness, headache and stomach pain. Those symptoms did not subside and by 11:30am on 02Oct2021 the reporter went to her house (her sister was there) and her mom was hunched over, unable to speak or keep her eyes open, and she was unable to stand. They could not get her to take in any fluids or eat. She appeared incoherent. They called her doctor who suggested they call the number. The paramedics came and her heart was barely beating. They did CPR and got a faint beat. By the time she arrived at (Hospital name/city name) she had cardiac arrest and hypothermia. Thankfully, they revived her. She was given antibiotics, electrolytes and was put on a ventilator and transducer pacemaker. Their concern was on 01Oct2021 at 1:59pm their mom was perfectly fine. By 5:30pm on 01Oct2021 everything changed. No one should have to suffer like this because of a shot. The events resulted in Emergency room/department or urgent care visit and Hospitalization for 3 days. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Aphasia, Cardiac arrest, Dizziness, Dysstasia
Clinical narrative: cardiac arrest/ her heart was barely beating; hypothermia; unable to speak or keep her eyes open; unable to speak or keep her eyes open; unable to stand; She appeared incoherent; terrible dizziness; headache; stomach pain; This is a spontaneous report from a contactable consumer. An 89-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: FF8841) via an unspecified route of administration, administered on the left arm on 01Oct2021 14:00 (at the age of 89-year-old) as dose 3 (booster), single for COVID-19 immunization. Medical history included hypertension. Concomitant medications included tramadol; meprobamate; and amlodipine. The patient previously received first dose of Comirnaty on 21Jan2021 03:00 PM (Batch/Lot No: EL1283) at the left arm and second dose on 15Feb2021 02:30 PM (Batch/Lot No: EW18909) at the left arm for COVID-19 immunisation. By 5:30pm on 01Oct2021 the patient began having terrible dizziness, headache and stomach pain. Those symptoms did not subside and by 11:30am on 02Oct2021 the reporter went to her house (her sister was there) and her mom was hunched over, unable to speak or keep her eyes open, and she was unable to stand. They could not get her to take in any fluids or eat. She appeared incoherent. They called her doctor who suggested they call the number. The paramedics came and her heart was barely beating. They did CPR and got a faint beat. By the time she arrived at (Hospital name/city name) she had cardiac arrest and hypothermia. Thankfully, they revived her. She was given antibiotics, electrolytes and was put on a ventilator and transducer pacemaker. Their concern was on 01Oct2021 at 1:59pm their mom was perfectly fine. By 5:30pm on 01Oct2021 everything changed. No one should have to suffer like this because of a shot. The events resulted in Emergency room/department or urgent care visit and Hospitalization for 3 days. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eye disorder, Headache, Hypothermia, Incoherent
Clinical narrative: cardiac arrest/ her heart was barely beating; hypothermia; unable to speak or keep her eyes open; unable to speak or keep her eyes open; unable to stand; She appeared incoherent; terrible dizziness; headache; stomach pain; This is a spontaneous report from a contactable consumer. An 89-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: FF8841) via an unspecified route of administration, administered on the left arm on 01Oct2021 14:00 (at the age of 89-year-old) as dose 3 (booster), single for COVID-19 immunization. Medical history included hypertension. Concomitant medications included tramadol; meprobamate; and amlodipine. The patient previously received first dose of Comirnaty on 21Jan2021 03:00 PM (Batch/Lot No: EL1283) at the left arm and second dose on 15Feb2021 02:30 PM (Batch/Lot No: EW18909) at the left arm for COVID-19 immunisation. By 5:30pm on 01Oct2021 the patient began having terrible dizziness, headache and stomach pain. Those symptoms did not subside and by 11:30am on 02Oct2021 the reporter went to her house (her sister was there) and her mom was hunched over, unable to speak or keep her eyes open, and she was unable to stand. They could not get her to take in any fluids or eat. She appeared incoherent. They called her doctor who suggested they call the number. The paramedics came and her heart was barely beating. They did CPR and got a faint beat. By the time she arrived at (Hospital name/city name) she had cardiac arrest and hypothermia. Thankfully, they revived her. She was given antibiotics, electrolytes and was put on a ventilator and transducer pacemaker. Their concern was on 01Oct2021 at 1:59pm their mom was perfectly fine. By 5:30pm on 01Oct2021 everything changed. No one should have to suffer like this because of a shot. The events resulted in Emergency room/department or urgent care visit and Hospitalization for 3 days. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Chest discomfort, Computerised tomogram head, Dizziness
Clinical narrative: cramps on both my hands; chest pressure; Hives on my face and neck; lightheaded; pain on my left arm; shortness of breath; Saturday 25Sep2021- around 6pm I started feeling tingling on my left hand; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 25Sep2021 15:00 (at the age of 37-year-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included allergy to honey. Concomitant medication included ethinylestradiol/norethisterone acetate (JUNEL) taken for birth control, start and stop date were not reported. The patient was not pregnant. The patient experienced shortness of breath (medically significant) on 26Sep2021 with outcome of recovering, tingling feet/hands (medically significant) on 25Sep2021 18:00 with outcome of recovering, lightheaded (medically significant) on 27Sep2021 with outcome of recovering, cramps of extremities (non-serious) on 29Sep2021 with outcome of recovering, pain in arm (non-serious) on 26Sep2021 with outcome of recovering, chest pressure (non-serious) on 27Sep2021 with outcome of recovering and hives on face and neck (non-serious) on 27Sep2021 with outcome of recovering. Saturday 25Sep2021 at around 6pm, she started feeling tingling on her left hand. Sunday 26Sep2021, she woke up with tingling on her left hand, pain on her left arm, shortness of breath at night. Monday 27Sep2021, she had tingling on left hand, shortness of breath, chest pressure, lightheaded, hives on her face and neck. She called the doctor whom advised to go to the hospital if symptoms persisted. Tuesday 28Sep2021, she went to the ER for shortness of breath, lightheaded and tingling on both hands at this point. She was sent home to drink lots of fluids and rest. Wednesday 29Sep2021, she had tingling and cramps on both hands and shortness of breath. Thursday 30Sep2021, she had tingling and cramps on  hands, shortness of breath. Friday 01Oct2021, she went to doctor's office in Advantage care physicians, with shortness of breath and pressure on chest. Tingling on hands stopped. Saturday 02Oct2021, she had  shortness of breath and pressure on chest. Sunday 03Oct2021, she was still experiencing shortness of breath and small chest pressure. The patient did not have COVID-19 prior to vaccination; it was unknown if she was tested for COVID-19 post vaccination.  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram, Paraesthesia, Urticaria
Clinical narrative: cramps on both my hands; chest pressure; Hives on my face and neck; lightheaded; pain on my left arm; shortness of breath; Saturday 25Sep2021- around 6pm I started feeling tingling on my left hand; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 25Sep2021 15:00 (at the age of 37-year-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included allergy to honey. Concomitant medication included ethinylestradiol/norethisterone acetate (JUNEL) taken for birth control, start and stop date were not reported. The patient was not pregnant. The patient experienced shortness of breath (medically significant) on 26Sep2021 with outcome of recovering, tingling feet/hands (medically significant) on 25Sep2021 18:00 with outcome of recovering, lightheaded (medically significant) on 27Sep2021 with outcome of recovering, cramps of extremities (non-serious) on 29Sep2021 with outcome of recovering, pain in arm (non-serious) on 26Sep2021 with outcome of recovering, chest pressure (non-serious) on 27Sep2021 with outcome of recovering and hives on face and neck (non-serious) on 27Sep2021 with outcome of recovering. Saturday 25Sep2021 at around 6pm, she started feeling tingling on her left hand. Sunday 26Sep2021, she woke up with tingling on her left hand, pain on her left arm, shortness of breath at night. Monday 27Sep2021, she had tingling on left hand, shortness of breath, chest pressure, lightheaded, hives on her face and neck. She called the doctor whom advised to go to the hospital if symptoms persisted. Tuesday 28Sep2021, she went to the ER for shortness of breath, lightheaded and tingling on both hands at this point. She was sent home to drink lots of fluids and rest. Wednesday 29Sep2021, she had tingling and cramps on both hands and shortness of breath. Thursday 30Sep2021, she had tingling and cramps on  hands, shortness of breath. Friday 01Oct2021, she went to doctor's office in Advantage care physicians, with shortness of breath and pressure on chest. Tingling on hands stopped. Saturday 02Oct2021, she had  shortness of breath and pressure on chest. Sunday 03Oct2021, she was still experiencing shortness of breath and small chest pressure. The patient did not have COVID-19 prior to vaccination; it was unknown if she was tested for COVID-19 post vaccination.  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Muscle spasms, Pain in extremity
Clinical narrative: cramps on both my hands; chest pressure; Hives on my face and neck; lightheaded; pain on my left arm; shortness of breath; Saturday 25Sep2021- around 6pm I started feeling tingling on my left hand; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 25Sep2021 15:00 (at the age of 37-year-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included allergy to honey. Concomitant medication included ethinylestradiol/norethisterone acetate (JUNEL) taken for birth control, start and stop date were not reported. The patient was not pregnant. The patient experienced shortness of breath (medically significant) on 26Sep2021 with outcome of recovering, tingling feet/hands (medically significant) on 25Sep2021 18:00 with outcome of recovering, lightheaded (medically significant) on 27Sep2021 with outcome of recovering, cramps of extremities (non-serious) on 29Sep2021 with outcome of recovering, pain in arm (non-serious) on 26Sep2021 with outcome of recovering, chest pressure (non-serious) on 27Sep2021 with outcome of recovering and hives on face and neck (non-serious) on 27Sep2021 with outcome of recovering. Saturday 25Sep2021 at around 6pm, she started feeling tingling on her left hand. Sunday 26Sep2021, she woke up with tingling on her left hand, pain on her left arm, shortness of breath at night. Monday 27Sep2021, she had tingling on left hand, shortness of breath, chest pressure, lightheaded, hives on her face and neck. She called the doctor whom advised to go to the hospital if symptoms persisted. Tuesday 28Sep2021, she went to the ER for shortness of breath, lightheaded and tingling on both hands at this point. She was sent home to drink lots of fluids and rest. Wednesday 29Sep2021, she had tingling and cramps on both hands and shortness of breath. Thursday 30Sep2021, she had tingling and cramps on  hands, shortness of breath. Friday 01Oct2021, she went to doctor's office in Advantage care physicians, with shortness of breath and pressure on chest. Tingling on hands stopped. Saturday 02Oct2021, she had  shortness of breath and pressure on chest. Sunday 03Oct2021, she was still experiencing shortness of breath and small chest pressure. The patient did not have COVID-19 prior to vaccination; it was unknown if she was tested for COVID-19 post vaccination.  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Urticaria
Clinical narrative: cramps on both my hands; chest pressure; Hives on my face and neck; lightheaded; pain on my left arm; shortness of breath; Saturday 25Sep2021- around 6pm I started feeling tingling on my left hand; This is a spontaneous report from a contactable consumer (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 25Sep2021 15:00 (at the age of 37-year-old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included allergy to honey. Concomitant medication included ethinylestradiol/norethisterone acetate (JUNEL) taken for birth control, start and stop date were not reported. The patient was not pregnant. The patient experienced shortness of breath (medically significant) on 26Sep2021 with outcome of recovering, tingling feet/hands (medically significant) on 25Sep2021 18:00 with outcome of recovering, lightheaded (medically significant) on 27Sep2021 with outcome of recovering, cramps of extremities (non-serious) on 29Sep2021 with outcome of recovering, pain in arm (non-serious) on 26Sep2021 with outcome of recovering, chest pressure (non-serious) on 27Sep2021 with outcome of recovering and hives on face and neck (non-serious) on 27Sep2021 with outcome of recovering. Saturday 25Sep2021 at around 6pm, she started feeling tingling on her left hand. Sunday 26Sep2021, she woke up with tingling on her left hand, pain on her left arm, shortness of breath at night. Monday 27Sep2021, she had tingling on left hand, shortness of breath, chest pressure, lightheaded, hives on her face and neck. She called the doctor whom advised to go to the hospital if symptoms persisted. Tuesday 28Sep2021, she went to the ER for shortness of breath, lightheaded and tingling on both hands at this point. She was sent home to drink lots of fluids and rest. Wednesday 29Sep2021, she had tingling and cramps on both hands and shortness of breath. Thursday 30Sep2021, she had tingling and cramps on  hands, shortness of breath. Friday 01Oct2021, she went to doctor's office in Advantage care physicians, with shortness of breath and pressure on chest. Tingling on hands stopped. Saturday 02Oct2021, she had  shortness of breath and pressure on chest. Sunday 03Oct2021, she was still experiencing shortness of breath and small chest pressure. The patient did not have COVID-19 prior to vaccination; it was unknown if she was tested for COVID-19 post vaccination.  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Bladder disorder, Blood glucose, Blood glucose abnormal
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Cardiac disorder, Chills, Condition aggravated
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Feeling abnormal, Headache
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Insomnia, Myalgia, Nausea, Pain
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Sciatic nerve injury, Tremor, Vomiting
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Rash
Clinical narrative: small rush; fatigue; This is a spontaneous report from contactable consumer (patient).  A male patient of an unspecified age received (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported he mentioned that when he received the first dose he manifested a small rush and fatigue for two days, on an unspecified date. It was reported that addition to the effects reported on Monday the patient also suffered from a constipated throat that did not allow him to swallow and swelling in the heel and foot of the right leg. The clinical outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No follow-up attempts are possible.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drooling, Dysarthria, Headache
Clinical narrative: headache; drooling; slurred speech; Patient received booster dose; Patient received booster dose; This is a spontaneous report from a contactable consumer.  A 56-year-old female patient received the third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, via an unspecified route of administration, administered in left arm on 01Oct2021 13:15 (Batch/Lot Number: FF8841) (at the age of 56 years old) as dose 3 (booster), single dose for Covid-19 immunisation. The patient medical history was not reported.  The patient was not pregnant at the time of vaccination. The first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) was administered on 29Dec2020 (Batch/Lot No: EL1284) at the age of 55 years old, and the second dose on 15Jan2021 (Batch/Lot No: EL3247) at the age of 55 years old, for Covid-19 immunisation. The patient's concomitant medications were not reported. The patient received the booster dose on 01Oct2021 at 13:15. After booster shot was given, patient was monitored for adverse/side effects and no reported/noted side effects. Patient walked back to her department and shortly after, at 16:00 on 01Oct2021, the patient began having headache, drooling, and had slurred speech. She did not lose consciousness. She was transferred/brought to emergency room and was admitted to the hospital on 01Oct2021. As of 04Oct2021, patient was still admitted for 3 days now receiving treatment and being monitored. Outcome of the events was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drooling, Dysarthria, Extra dose administered, Headache, Off label use
Clinical narrative: headache; drooling; slurred speech; Patient received booster dose; Patient received booster dose; This is a spontaneous report from a contactable consumer.  A 56-year-old female patient received the third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, via an unspecified route of administration, administered in left arm on 01Oct2021 13:15 (Batch/Lot Number: FF8841) (at the age of 56 years old) as dose 3 (booster), single dose for Covid-19 immunisation. The patient medical history was not reported.  The patient was not pregnant at the time of vaccination. The first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) was administered on 29Dec2020 (Batch/Lot No: EL1284) at the age of 55 years old, and the second dose on 15Jan2021 (Batch/Lot No: EL3247) at the age of 55 years old, for Covid-19 immunisation. The patient's concomitant medications were not reported. The patient received the booster dose on 01Oct2021 at 13:15. After booster shot was given, patient was monitored for adverse/side effects and no reported/noted side effects. Patient walked back to her department and shortly after, at 16:00 on 01Oct2021, the patient began having headache, drooling, and had slurred speech. She did not lose consciousness. She was transferred/brought to emergency room and was admitted to the hospital on 01Oct2021. As of 04Oct2021, patient was still admitted for 3 days now receiving treatment and being monitored. Outcome of the events was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a 65 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, expiry: 21-SEP-2021) 0.5 ml, administered on 23-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 23-SEP-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20211006798 and 20211019260.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 42 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 204A21A expiry: 21-SEP-2021) 0.5 ml, start therapy date was not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211021248 and 20211006668.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED DOSE OF JANSSEN COVID VACCINE; This spontaneous report received from a health care professional concerned a 31 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: It was unknown if the patient was alcoholic, smoker, had allergies, and drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A expiry: 21/SEP/2021) .5 ml, administered on 04-OCT-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-OCT-2021, the patient experienced administration of expired dose of janssen covid vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired dose of janssen covid vaccine was not reported. This report was non-serious. This case, from the same reporter is linked.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED VACCINE ADMINISTRATION; This spontaneous report received from a health care professional concerned a 58 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: It was unknown if the patient had any allergies or history of drug abuse, it was also unknown whether patient was an alcoholic or smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, expiry: 21-SEP-2021) 0.5 ml, administered on 27-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-SEP-2021, the patient experienced expired vaccine administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administration was not reported. This report was non-serious. This case, from the same reporter is linked to 20211018746, 20211018754, 20211018789, 20211009653, 20211009632, 20211006798, 20211006668, 20211006371, 20211019260, 20211018761, 20211018742 and 20211018630.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED DOSE OF JANSSEN COVID VACCINE; This spontaneous report received from a health care professional concerned a 33 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: It was unknown if the patient was alcohol user, smoker, had allergies and drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, and expiry: 21-SEP-2021) .5 ml, start therapy date was not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced administration of expired dose of janssen covid vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired dose of janssen covid vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211018746, 20211006371, 20211006668, 20211006798, 20211009632, 20211009653, 20211018630, 20211018742, 20211018761, 20211018789, 20211019260 and 20211019478.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: RECEIVED EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 22 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, and expiry: 21-SEP-21) .5 ml, administered on 27-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-SEP-2021, the patient experienced received expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211018789.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 27 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, and expiry: 20-SEP-2021) .5 ml, start therapy date was not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Back pain, Blood pressure increased, Cardiac discomfort, Chest discomfort
Clinical narrative: felt a sharp stabbing pain in my heart that lasted seconds; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; had slightly elevated blood pressure of 146/81; pulse of 94; fatigue; felt a slight pressure on my heart/chest tightness; heart was being squeezed; chest pain; slight throat tightness; upper back pain/It hurt more when lying down or bending forward; upper back tightness; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; This is a spontaneous report from a contactable consumer. A 39-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right at the age of 39 years old on 22Sep2021 15:15 (Batch/Lot Number: FF2588) as dose 1, single for covid-19 immunisation. The patient had no medical history. Concomitant medications included buspirone (BUSPIRONE); bupropion (BUPROPION); finasteride (FINASTERIDE). On 23Sep2021, 24 hours after the vaccine, the patient felt a sharp stabbing pain in his heart that lasted seconds. Over the next 24 hours, the patient felt 7 to 8 more stabbing pains in his heart. Over the next few days in Sep2021, he felt a slight pressure on his heart, but it was not painful. On the sixth day the pressure built to be very painful. It felt like his heart was being squeezed. He had chest pain, chest tightness, slight throat tightness, heart pain, upper back pain, upper back tightness and shooting pains through my jaw and left arm and a few more stabbing pains in his heart. It hurt more when lying down or bending forward. He went to the Urgent Care on day 7 to have his vitals checked. The patient had slightly elevated blood pressure of 146/81 and pulse of 94. He has scheduled an appointment with a cardiologist. No treatment was received. The patient had a slight pain in his upper left chest still and fatigue. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dizziness, Electrocardiogram normal, Fatigue, Muscle tightness
Clinical narrative: felt a sharp stabbing pain in my heart that lasted seconds; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; had slightly elevated blood pressure of 146/81; pulse of 94; fatigue; felt a slight pressure on my heart/chest tightness; heart was being squeezed; chest pain; slight throat tightness; upper back pain/It hurt more when lying down or bending forward; upper back tightness; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; This is a spontaneous report from a contactable consumer. A 39-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right at the age of 39 years old on 22Sep2021 15:15 (Batch/Lot Number: FF2588) as dose 1, single for covid-19 immunisation. The patient had no medical history. Concomitant medications included buspirone (BUSPIRONE); bupropion (BUPROPION); finasteride (FINASTERIDE). On 23Sep2021, 24 hours after the vaccine, the patient felt a sharp stabbing pain in his heart that lasted seconds. Over the next 24 hours, the patient felt 7 to 8 more stabbing pains in his heart. Over the next few days in Sep2021, he felt a slight pressure on his heart, but it was not painful. On the sixth day the pressure built to be very painful. It felt like his heart was being squeezed. He had chest pain, chest tightness, slight throat tightness, heart pain, upper back pain, upper back tightness and shooting pains through my jaw and left arm and a few more stabbing pains in his heart. It hurt more when lying down or bending forward. He went to the Urgent Care on day 7 to have his vitals checked. The patient had slightly elevated blood pressure of 146/81 and pulse of 94. He has scheduled an appointment with a cardiologist. No treatment was received. The patient had a slight pain in his upper left chest still and fatigue. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal discomfort, Pain, Pain in extremity, Pain in jaw
Clinical narrative: felt a sharp stabbing pain in my heart that lasted seconds; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; had slightly elevated blood pressure of 146/81; pulse of 94; fatigue; felt a slight pressure on my heart/chest tightness; heart was being squeezed; chest pain; slight throat tightness; upper back pain/It hurt more when lying down or bending forward; upper back tightness; shooting pains through my jaw and left arm and a few more stabbing pains in my heart; This is a spontaneous report from a contactable consumer. A 39-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right at the age of 39 years old on 22Sep2021 15:15 (Batch/Lot Number: FF2588) as dose 1, single for covid-19 immunisation. The patient had no medical history. Concomitant medications included buspirone (BUSPIRONE); bupropion (BUPROPION); finasteride (FINASTERIDE). On 23Sep2021, 24 hours after the vaccine, the patient felt a sharp stabbing pain in his heart that lasted seconds. Over the next 24 hours, the patient felt 7 to 8 more stabbing pains in his heart. Over the next few days in Sep2021, he felt a slight pressure on his heart, but it was not painful. On the sixth day the pressure built to be very painful. It felt like his heart was being squeezed. He had chest pain, chest tightness, slight throat tightness, heart pain, upper back pain, upper back tightness and shooting pains through my jaw and left arm and a few more stabbing pains in his heart. It hurt more when lying down or bending forward. He went to the Urgent Care on day 7 to have his vitals checked. The patient had slightly elevated blood pressure of 146/81 and pulse of 94. He has scheduled an appointment with a cardiologist. No treatment was received. The patient had a slight pain in his upper left chest still and fatigue. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.